Book Your Seats:
- 00Days
- 00Hrs
- 00Mins
- 00Secs
6.30pm - Midnight | 18 November 2024
City Central @ Honourable Artillery CompanyLondon, UKBIOTECH COMPANY OF THE YEAR OFFICIAL FINALIST ROSTER
This award recognises a European Biotech (drug discovery, pre-clinical, clinical, OTM therapeutic) company that has demonstrated a superior excellence in strategy, process, focus and execution to create significant value for patients, investors, employees and the broader life science community.
BIOTECH COMPANY OF THE YEAR OFFICIAL FINALIST ROSTER
Qualifying criteria:
- Open to all Biotech therapeutic companies with European Headquarters
- Open to all biotech companies with a market capitalisation that is €10bn or less.
- Submission relates to activities achieved in the period between 1 September 2023 and 1 August 2024
Judges will be paying particular attention to:
- Targeting of unmet medical need / use of innovative approaches to pipeline development
- Pipeline progress through drug discovery / pre-clinical / clinical stages / market approval
- Closure of fundraises and strategic financing rounds
- Key stages of strategic development / partnerships
- Implementation of new technologies, processes for strategic advantage
